Joint Plus Effervescent Tablets
Natural health product licensed in Canada
- Other names
- Future Life Joint Plus Effervescent Tablets, Glucosamine Plus Effervescent Tablets
- Licence holder
- NEW WEST NUTRACEUTICALS INC
- NPN or DIN-HM
- 80079996
- Status
- Active licence
- Licence date
- 12 September 2017
- Revision date
- 26 January 2026
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose Source : Chlorhydrate de glucosamine | 500 milligramme | Not calculated |
| Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose Source : Exosquelette de crabe | 500 milligramme | Not calculated |
| Sulfate de chondroïtine Source : Sulfate de chondroïtine | 400 milligramme | Not calculated |
| Sulfate de chondroïtine Source : Bos taurus - cartilage | 400 milligramme | Not calculated |
| Sulfone de diméthyl Source : Sulfone de diméthyl | 200 milligramme | Not calculated |
Non-medicinal ingredients
Acid citrique, Bicarbonate de sodium, Saccharinate de sodium, Benzoate de sodium, Saveur de fraise
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Comprimé ; maximum: 3 Comprimé | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to relieve (joint) pain associated with oasteoarthritis (of the knee). Helps to protect against the deterioration of cartilage A factor in maintaining healthy cartilage and/or joint health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80079996
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.